Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease
| Image |  |
|---|---|
| Description | scientific article published on 01 December 2018 |
| Author/s |
author: Federico Argüelles-Arias María Guerra Veloz Angel Vilches-Arenas |
| Publication date | December 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |